Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Dana-Farber Cancer Institute
University of Maryland, Baltimore
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Essen Biotech
Thomas Jefferson University
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Wake Forest University Health Sciences
Shenzhen University General Hospital
Columbia University
University of California, Davis
Astex Pharmaceuticals, Inc.
Kyowa Kirin Co., Ltd.
Hellenic Society of Hematology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chongqing Precision Biotech Co., Ltd
H. Lee Moffitt Cancer Center and Research Institute
Hellenic Society of Hematology
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
University Hospital Southampton NHS Foundation Trust
PrECOG, LLC.
University of Arkansas
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
Alliance for Clinical Trials in Oncology
Celldex Therapeutics
M.D. Anderson Cancer Center
Threshold Pharmaceuticals
University of Turin, Italy
Nantes University Hospital
Singapore General Hospital
Senesco Technologies, Inc.
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Tennessee
Prolexys Pharmaceuticals
National Cancer Institute (NCI)
Asan Medical Center
Washington University School of Medicine